期刊文献+

3种动物经消化道给予S-多沙唑嗪甲磺酸盐与S-多沙唑嗪盐酸盐后血药浓度比较 被引量:1

Plasma Concentration Comparation Between S-doxazosin Mesylate and S-doxazosin Hydrochloride Administered Via Digestive System in Three Animals
下载PDF
导出
摘要 目的观察3种动物经消化道给予S-多沙唑嗪甲磺酸盐和S-多沙唑嗪盐酸盐后血药浓度变化。方法将大鼠麻醉后灌胃给予S-多沙唑嗪甲磺酸盐和S-多沙唑嗪盐酸盐5.0μmol·kg^-1,观察180 min,经股静脉采血;兔麻醉后经十二指肠给予S-多沙唑嗪甲磺酸盐和S-多沙唑嗪盐酸盐,2.8μmol·kg^-1,观察120 min,经股静脉采血;猫麻醉后经十二指肠给予S-多沙唑嗪甲磺酸盐和S-多沙唑嗪盐酸盐2.0μmol·kg^-1,观察180 min,经股静脉采血。均采用高效液相色谱荧光法检测血浆药物浓度。结果大鼠给药后180 min,S-多沙唑嗪甲磺酸盐和盐酸盐的最高血药浓度分别为(51.2±31.0)和(30.6±17.5)ng·mL^-1;S-多沙唑嗪甲磺酸盐和盐酸盐在0~180 min内的浓度-时间曲线下面积之比为1.4:1。兔经十二指肠给药后120 min,S-多沙唑嗪甲磺酸盐和盐酸盐的最高血药浓度分别为(267.1±63.0)和(226.9±123.2)ng·mL^-1;S-多沙唑嗪甲磺酸盐和盐酸盐在0~120 min内的浓度-时间曲线下面积之比为1.1:1。猫经十二指肠给药后180 min,S-多沙唑嗪甲磺酸盐和盐酸盐的最高血药浓度分别是(1046.4±606.1)和(669.3±332.7)ng·mL^-1;S-多沙唑嗪甲磺酸盐和盐酸盐在0~180 min内的浓度-时间曲线下面积之比为2.4:1。结论S-多沙唑嗪甲磺酸盐经消化道吸收优于S-多沙唑嗪盐酸盐。 Objective To compare the plasma concentrations of S-doxazosin mesylate and S-doxazosin hydrochloride aderministered via digestive system in rats, rabbits and cats, respectively. Methods S-Doxazosin mesylate and S-doxazosin hydrochloride were administered via different way in three different anesthetized animals at different dose, after different time of observing, respectively, blood samples were collected via femoral vein. then the plasma drug concentrations were determined by using a high performance liquid chromatograpy (HPLC) assay. Results The maximum plasma concentration for S-doxazosin mesylate was ( 51.2 ± 31.0) ng· mL^-1 , and that for S-doxazosin hydrochloride was (30.6 ±17.5 ) ng· mL^-1 180 min after p. o. S-doxazosin mesylate and S-doxazosin hydrochloride in rats. The ratio of AUC for S-doxazosin mesylate over hydrochloride within 0- 180 min was 1.4 : 1. The maximum plasma concentration for S-doxazosin mesylate and hydrochloride was (267.1 ± 63.0) and (226.9 ± 123.2) ng· mL^-1 , respectively, 120 min after intraduodenal administration of drugs in rabbits. The ratio of AUC for S-doxazosin mesylate over hydrochloride within 0 - 120 min was 1.1 : 1. The maximum plasma concentration for S-doxazosin mesylate and hydrochloride was (1 046.4± 606.1 )and (669.3 ± 332.7) ng· mL^-1 ,respectively, 180 min after intraduodenal administration in cats. The ratio of AUC for S-doxazosin mesylate over S-doxazosin hydrochloride within 0 - 180 min was 2.4 : 1. Conclusion The results indicate that the absorption of S-doxazosin mesylate administered via digestive system is better than that of S-doxazosin hydrochloride.
出处 《医药导报》 CAS 2007年第8期837-840,共4页 Herald of Medicine
基金 河北省自然科学基金资助项目(基金编号:C2006000802)
关键词 S-多沙唑嗪甲磺酸盐 S-多沙唑嗪盐酸盐 色谱法 高效液相 药物吸收 S-doxazosin mesylate S-doxazosin hydrochloride HPLC Drug absorption
  • 相关文献

参考文献4

二级参考文献11

  • 1谭敦勇,姚兴海,赵东,汤健,唐朝枢.降钙素基因相关肽对内皮素释放的影响[J].中国病理生理杂志,1994,10(5):545-547. 被引量:49
  • 2DeLeeuw P W, Birkenhager W H. Treating hypertension is more important than the choice of agent, results from the largest clinical trial until now [J]. Ned Tijdschr Geneeskd,2003 ,147 (15): 685 -689.
  • 3Levy D, Walmsley P. Principal results of the hypertension and lipid trial (HALT) -A multicenter study of doxazosin in patients with hypertension [J]. Am Heart J, 1996,131 (5):966 - 972.
  • 4Jimenez-Garcia R, Anegon M, Esteban J, et al. Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therape utic system (GITS) formulation in elderly hypertensive patients [J]. Int J Clin Pract, 2003,57 (4): 267 - 272.
  • 5Black H R. Doxazosin as combination therapy for patients with stage 1 and stage 2 hypertension[J] . J Cardiovasc Pharmacol, 2003,41 (6): 866 - 869.
  • 6Watson R E, Supowit S C, Zhao H, et al. Role of sensory nervous system vasoactive peptides in hypertension [J].Braz J Med Biol Res, 2002,35(9) :1033 - 1045.
  • 7Supowist S C, Zhao H, Dipette D J. Nerve growth factor enhances calcitonin gene-related peptide expression in the spontaneously hypertensive rat[J]. Hypertention, 2001, 37(2):728-732.
  • 8俞犄,王义明,罗国安.氧氟沙星对映体的毛细管电泳手性分离[J].药学学报,1997,32(3):203-206. 被引量:23
  • 9牛长群,任雷鸣.3种新型α_1-受体阻断剂的高效毛细管电泳手性分离[J].药学学报,2000,35(6):451-453. 被引量:14
  • 10李菁,杨天伦,郑知刚.福辛普利对原发性高血压患者降钙素基因相关肽血浆浓度的影响[J].中日友好医院学报,2002,16(1):14-16. 被引量:1

共引文献46

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部